nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibutilide—KCNJ11—ATP sensitive Potassium channels—ABCC9—uterine cancer	0.067	0.237	CbGpPWpGaD
Ibutilide—KCNK6—female reproductive system—uterine cancer	0.036	0.0731	CbGeAlD
Ibutilide—KCNK1—myometrium—uterine cancer	0.0274	0.0555	CbGeAlD
Ibutilide—KCNH6—renal system—uterine cancer	0.0238	0.0483	CbGeAlD
Ibutilide—KCNK1—uterine cervix—uterine cancer	0.0213	0.0432	CbGeAlD
Ibutilide—KCNH6—uterus—uterine cancer	0.0212	0.043	CbGeAlD
Ibutilide—KCNK1—decidua—uterine cancer	0.0203	0.0412	CbGeAlD
Ibutilide—KCNK1—renal system—uterine cancer	0.0199	0.0404	CbGeAlD
Ibutilide—KCNK1—endometrium—uterine cancer	0.0193	0.0391	CbGeAlD
Ibutilide—KCNH6—female reproductive system—uterine cancer	0.0191	0.0387	CbGeAlD
Ibutilide—KCNK1—mammalian vulva—uterine cancer	0.0186	0.0378	CbGeAlD
Ibutilide—KCNK1—uterus—uterine cancer	0.0178	0.036	CbGeAlD
Ibutilide—CACNB1—female gonad—uterine cancer	0.0172	0.0349	CbGeAlD
Ibutilide—KCNK6—Potassium Channels—ABCC9—uterine cancer	0.0171	0.0607	CbGpPWpGaD
Ibutilide—CACNA1C—myometrium—uterine cancer	0.0169	0.0342	CbGeAlD
Ibutilide—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0151	0.0673	CcSEcCtD
Ibutilide—KCNK1—Potassium Channels—ABCC9—uterine cancer	0.0146	0.0516	CbGpPWpGaD
Ibutilide—KCNK1—female gonad—uterine cancer	0.0145	0.0295	CbGeAlD
Ibutilide—KCNK1—vagina—uterine cancer	0.0144	0.0293	CbGeAlD
Ibutilide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.013	0.0461	CbGpPWpGaD
Ibutilide—CACNA1C—smooth muscle tissue—uterine cancer	0.0128	0.0259	CbGeAlD
Ibutilide—CACNA1C—decidua—uterine cancer	0.0125	0.0254	CbGeAlD
Ibutilide—KCNH6—Potassium Channels—ABCC9—uterine cancer	0.0116	0.0412	CbGpPWpGaD
Ibutilide—KCNJ11—female reproductive system—uterine cancer	0.0116	0.0235	CbGeAlD
Ibutilide—CACNB1—lymph node—uterine cancer	0.0111	0.0225	CbGeAlD
Ibutilide—KCNJ11—female gonad—uterine cancer	0.0105	0.0214	CbGeAlD
Ibutilide—CACNA2D1—female gonad—uterine cancer	0.0104	0.0211	CbGeAlD
Ibutilide—KCNH7—Potassium Channels—ABCC9—uterine cancer	0.0104	0.0368	CbGpPWpGaD
Ibutilide—CACNA2D1—vagina—uterine cancer	0.0104	0.021	CbGeAlD
Ibutilide—KCNH2—myometrium—uterine cancer	0.0101	0.0204	CbGeAlD
Ibutilide—CACNA1C—female reproductive system—uterine cancer	0.00984	0.02	CbGeAlD
Ibutilide—KCNK1—lymph node—uterine cancer	0.00934	0.0189	CbGeAlD
Ibutilide—CACNA1C—vagina—uterine cancer	0.0089	0.018	CbGeAlD
Ibutilide—Supraventricular extrasystoles—Epirubicin—uterine cancer	0.00842	0.0375	CcSEcCtD
Ibutilide—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00794	0.0353	CcSEcCtD
Ibutilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.00783	0.0277	CbGpPWpGaD
Ibutilide—KCNH2—uterine cervix—uterine cancer	0.00782	0.0159	CbGeAlD
Ibutilide—Supraventricular extrasystoles—Doxorubicin—uterine cancer	0.00779	0.0347	CcSEcCtD
Ibutilide—Sinus tachycardia—Epirubicin—uterine cancer	0.00779	0.0346	CcSEcCtD
Ibutilide—KCNK6—Neuronal System—ABCC9—uterine cancer	0.00747	0.0265	CbGpPWpGaD
Ibutilide—KCNH2—renal system—uterine cancer	0.00732	0.0148	CbGeAlD
Ibutilide—Sinus tachycardia—Doxorubicin—uterine cancer	0.00721	0.0321	CcSEcCtD
Ibutilide—KCNH2—endometrium—uterine cancer	0.00708	0.0144	CbGeAlD
Ibutilide—KCNJ11—lymph node—uterine cancer	0.00677	0.0137	CbGeAlD
Ibutilide—CACNA2D1—lymph node—uterine cancer	0.0067	0.0136	CbGeAlD
Ibutilide—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00657	0.0292	CcSEcCtD
Ibutilide—KCNH2—uterus—uterine cancer	0.00652	0.0132	CbGeAlD
Ibutilide—KCNK1—Neuronal System—ABCC9—uterine cancer	0.00635	0.0225	CbGpPWpGaD
Ibutilide—Bundle branch block—Epirubicin—uterine cancer	0.00622	0.0277	CcSEcCtD
Ibutilide—KCNH7—Circadian rythm related genes—STAR—uterine cancer	0.00589	0.0209	CbGpPWpGaD
Ibutilide—KCNH2—female reproductive system—uterine cancer	0.00586	0.0119	CbGeAlD
Ibutilide—CACNA1C—lymph node—uterine cancer	0.00575	0.0117	CbGeAlD
Ibutilide—Bundle branch block—Doxorubicin—uterine cancer	0.00575	0.0256	CcSEcCtD
Ibutilide—KCNH2—female gonad—uterine cancer	0.00533	0.0108	CbGeAlD
Ibutilide—KCNH2—vagina—uterine cancer	0.0053	0.0108	CbGeAlD
Ibutilide—CACNB1—Axon guidance—PLXNA3—uterine cancer	0.00516	0.0183	CbGpPWpGaD
Ibutilide—KCNJ11—Potassium Channels—ABCC9—uterine cancer	0.00514	0.0182	CbGpPWpGaD
Ibutilide—KCNH6—Neuronal System—ABCC9—uterine cancer	0.00508	0.018	CbGpPWpGaD
Ibutilide—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00507	0.0225	CcSEcCtD
Ibutilide—KCNH7—Circadian rythm related genes—HNF1B—uterine cancer	0.0048	0.017	CbGpPWpGaD
Ibutilide—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00458	0.0162	CbGpPWpGaD
Ibutilide—KCNH7—Neuronal System—ABCC9—uterine cancer	0.00453	0.016	CbGpPWpGaD
Ibutilide—Cardiac failure congestive—Etoposide—uterine cancer	0.00448	0.0199	CcSEcCtD
Ibutilide—KCNH2—Potassium Channels—ABCC9—uterine cancer	0.00439	0.0156	CbGpPWpGaD
Ibutilide—Syncope—Progesterone—uterine cancer	0.00429	0.0191	CcSEcCtD
Ibutilide—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00424	0.0189	CcSEcCtD
Ibutilide—Palpitations—Progesterone—uterine cancer	0.00423	0.0188	CcSEcCtD
Ibutilide—Loss of consciousness—Progesterone—uterine cancer	0.0042	0.0187	CcSEcCtD
Ibutilide—Hypertension—Progesterone—uterine cancer	0.00413	0.0184	CcSEcCtD
Ibutilide—CACNA1C—Alzheimers Disease—MME—uterine cancer	0.00412	0.0146	CbGpPWpGaD
Ibutilide—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00392	0.0174	CcSEcCtD
Ibutilide—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00389	0.0173	CcSEcCtD
Ibutilide—Shock—Progesterone—uterine cancer	0.00384	0.0171	CcSEcCtD
Ibutilide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00383	0.017	CcSEcCtD
Ibutilide—Tachycardia—Progesterone—uterine cancer	0.00381	0.0169	CcSEcCtD
Ibutilide—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00381	0.0169	CcSEcCtD
Ibutilide—CACNB1—Neuronal System—ABCC9—uterine cancer	0.00375	0.0133	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—PLXNA3—uterine cancer	0.00368	0.013	CbGpPWpGaD
Ibutilide—Hypotension—Progesterone—uterine cancer	0.00365	0.0162	CcSEcCtD
Ibutilide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00348	0.0155	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Epirubicin—uterine cancer	0.00347	0.0155	CcSEcCtD
Ibutilide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00345	0.0154	CcSEcCtD
Ibutilide—KCNH2—lymph node—uterine cancer	0.00343	0.00696	CbGeAlD
Ibutilide—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00336	0.0119	CbGpPWpGaD
Ibutilide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00331	0.0147	CcSEcCtD
Ibutilide—CACNB1—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.00325	0.0115	CbGpPWpGaD
Ibutilide—Atrioventricular block—Epirubicin—uterine cancer	0.00324	0.0144	CcSEcCtD
Ibutilide—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00321	0.0143	CcSEcCtD
Ibutilide—Ventricular tachycardia—Epirubicin—uterine cancer	0.00314	0.014	CcSEcCtD
Ibutilide—KCNH7—Circadian rythm related genes—EZH2—uterine cancer	0.00308	0.0109	CbGpPWpGaD
Ibutilide—Renal failure—Etoposide—uterine cancer	0.00308	0.0137	CcSEcCtD
Ibutilide—Atrioventricular block—Doxorubicin—uterine cancer	0.00299	0.0133	CcSEcCtD
Ibutilide—Ventricular tachycardia—Doxorubicin—uterine cancer	0.0029	0.0129	CcSEcCtD
Ibutilide—CACNA1C—Axon guidance—PLXNA3—uterine cancer	0.00269	0.00955	CbGpPWpGaD
Ibutilide—Dizziness—Progesterone—uterine cancer	0.00258	0.0115	CcSEcCtD
Ibutilide—Cardiac failure congestive—Epirubicin—uterine cancer	0.00251	0.0112	CcSEcCtD
Ibutilide—Headache—Progesterone—uterine cancer	0.00245	0.0109	CcSEcCtD
Ibutilide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.0104	CcSEcCtD
Ibutilide—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00232	0.0103	CcSEcCtD
Ibutilide—Nausea—Progesterone—uterine cancer	0.00232	0.0103	CcSEcCtD
Ibutilide—KCNJ11—Neuronal System—ABCC9—uterine cancer	0.00224	0.00795	CbGpPWpGaD
Ibutilide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00986	CcSEcCtD
Ibutilide—KCNJ11—Integration of energy metabolism—STK11—uterine cancer	0.00218	0.00771	CbGpPWpGaD
Ibutilide—Loss of consciousness—Etoposide—uterine cancer	0.00215	0.00957	CcSEcCtD
Ibutilide—Hypertension—Etoposide—uterine cancer	0.00211	0.0094	CcSEcCtD
Ibutilide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00935	CcSEcCtD
Ibutilide—Orthostatic hypotension—Epirubicin—uterine cancer	0.00208	0.00925	CcSEcCtD
Ibutilide—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00204	0.00725	CbGpPWpGaD
Ibutilide—Tachycardia—Etoposide—uterine cancer	0.00195	0.00867	CcSEcCtD
Ibutilide—CACNB1—Developmental Biology—HNF1B—uterine cancer	0.00193	0.00685	CbGpPWpGaD
Ibutilide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00192	0.00856	CcSEcCtD
Ibutilide—CACNA1C—Developmental Biology—PLXNA3—uterine cancer	0.00192	0.00681	CbGpPWpGaD
Ibutilide—KCNH2—Neuronal System—ABCC9—uterine cancer	0.00192	0.0068	CbGpPWpGaD
Ibutilide—CACNB1—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.0019	0.00674	CbGpPWpGaD
Ibutilide—CACNA1C—Integration of energy metabolism—STK11—uterine cancer	0.0019	0.00672	CbGpPWpGaD
Ibutilide—Hypotension—Etoposide—uterine cancer	0.00187	0.0083	CcSEcCtD
Ibutilide—Renal failure—Epirubicin—uterine cancer	0.00173	0.00767	CcSEcCtD
Ibutilide—CACNA1C—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.0017	0.00602	CbGpPWpGaD
Ibutilide—Nausea—Dactinomycin—uterine cancer	0.00164	0.00729	CcSEcCtD
Ibutilide—CACNB1—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.00164	0.0058	CbGpPWpGaD
Ibutilide—Bradycardia—Epirubicin—uterine cancer	0.0016	0.00713	CcSEcCtD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.0016	0.00568	CbGpPWpGaD
Ibutilide—Renal failure—Doxorubicin—uterine cancer	0.0016	0.0071	CcSEcCtD
Ibutilide—Bradycardia—Doxorubicin—uterine cancer	0.00148	0.0066	CcSEcCtD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.00148	0.00524	CbGpPWpGaD
Ibutilide—CACNB1—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.00139	0.00493	CbGpPWpGaD
Ibutilide—Dizziness—Etoposide—uterine cancer	0.00132	0.00587	CcSEcCtD
Ibutilide—Headache—Etoposide—uterine cancer	0.00125	0.00556	CcSEcCtD
Ibutilide—Syncope—Epirubicin—uterine cancer	0.00123	0.00547	CcSEcCtD
Ibutilide—Palpitations—Epirubicin—uterine cancer	0.00121	0.00539	CcSEcCtD
Ibutilide—Loss of consciousness—Epirubicin—uterine cancer	0.00121	0.00536	CcSEcCtD
Ibutilide—Nausea—Etoposide—uterine cancer	0.00119	0.00528	CcSEcCtD
Ibutilide—Hypertension—Epirubicin—uterine cancer	0.00118	0.00527	CcSEcCtD
Ibutilide—Syncope—Doxorubicin—uterine cancer	0.00114	0.00506	CcSEcCtD
Ibutilide—Palpitations—Doxorubicin—uterine cancer	0.00112	0.00499	CcSEcCtD
Ibutilide—Loss of consciousness—Doxorubicin—uterine cancer	0.00112	0.00496	CcSEcCtD
Ibutilide—Shock—Epirubicin—uterine cancer	0.0011	0.0049	CcSEcCtD
Ibutilide—Hypertension—Doxorubicin—uterine cancer	0.0011	0.00487	CcSEcCtD
Ibutilide—Tachycardia—Epirubicin—uterine cancer	0.00109	0.00486	CcSEcCtD
Ibutilide—KCNH7—Circadian rythm related genes—PTEN—uterine cancer	0.00108	0.00384	CbGpPWpGaD
Ibutilide—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00107	0.00379	CbGpPWpGaD
Ibutilide—Hypotension—Epirubicin—uterine cancer	0.00105	0.00465	CcSEcCtD
Ibutilide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.00104	0.0037	CbGpPWpGaD
Ibutilide—KCNH7—Circadian rythm related genes—EP300—uterine cancer	0.00103	0.00366	CbGpPWpGaD
Ibutilide—Shock—Doxorubicin—uterine cancer	0.00102	0.00453	CcSEcCtD
Ibutilide—Tachycardia—Doxorubicin—uterine cancer	0.00101	0.0045	CcSEcCtD
Ibutilide—CACNA1C—Developmental Biology—HNF1B—uterine cancer	0.00101	0.00358	CbGpPWpGaD
Ibutilide—CACNA1C—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000994	0.00352	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—MET—uterine cancer	0.000981	0.00348	CbGpPWpGaD
Ibutilide—Hypotension—Doxorubicin—uterine cancer	0.000968	0.0043	CcSEcCtD
Ibutilide—KCNK6—Neuronal System—HRAS—uterine cancer	0.000898	0.00318	CbGpPWpGaD
Ibutilide—CACNA1C—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000856	0.00303	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—SMAD3—uterine cancer	0.000854	0.00303	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—SRD5A2—uterine cancer	0.000782	0.00277	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—NDUFB11—uterine cancer	0.000782	0.00277	CbGpPWpGaD
Ibutilide—KCNK1—Neuronal System—HRAS—uterine cancer	0.000763	0.00271	CbGpPWpGaD
Ibutilide—Dizziness—Epirubicin—uterine cancer	0.00074	0.00329	CcSEcCtD
Ibutilide—KCNH7—Circadian rythm related genes—TP53—uterine cancer	0.000739	0.00262	CbGpPWpGaD
Ibutilide—CACNA1C—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000727	0.00258	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—ERBB2—uterine cancer	0.000717	0.00254	CbGpPWpGaD
Ibutilide—Headache—Epirubicin—uterine cancer	0.000701	0.00312	CcSEcCtD
Ibutilide—CACNB1—Developmental Biology—MET—uterine cancer	0.0007	0.00248	CbGpPWpGaD
Ibutilide—Dizziness—Doxorubicin—uterine cancer	0.000685	0.00305	CcSEcCtD
Ibutilide—CACNA1C—Metabolism—SRD5A2—uterine cancer	0.000682	0.00242	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—NDUFB11—uterine cancer	0.000682	0.00242	CbGpPWpGaD
Ibutilide—CACNA1C—Alzheimers Disease—TP53—uterine cancer	0.000674	0.00239	CbGpPWpGaD
Ibutilide—Nausea—Epirubicin—uterine cancer	0.000665	0.00296	CcSEcCtD
Ibutilide—Headache—Doxorubicin—uterine cancer	0.000649	0.00289	CcSEcCtD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000625	0.00221	CbGpPWpGaD
Ibutilide—Nausea—Doxorubicin—uterine cancer	0.000615	0.00274	CcSEcCtD
Ibutilide—KCNH6—Neuronal System—HRAS—uterine cancer	0.00061	0.00216	CbGpPWpGaD
Ibutilide—CACNB1—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000587	0.00208	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000576	0.00204	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—STAR—uterine cancer	0.000565	0.002	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKR1B1—uterine cancer	0.000565	0.002	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—VEGFA—uterine cancer	0.000552	0.00196	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—NRAS—uterine cancer	0.000546	0.00193	CbGpPWpGaD
Ibutilide—KCNH7—Neuronal System—HRAS—uterine cancer	0.000544	0.00193	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000536	0.0019	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—MET—uterine cancer	0.000513	0.00182	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—ERBB2—uterine cancer	0.000512	0.00181	CbGpPWpGaD
Ibutilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000507	0.0018	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKR1B1—uterine cancer	0.000493	0.00175	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—STAR—uterine cancer	0.000493	0.00175	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—KRAS—uterine cancer	0.00047	0.00166	CbGpPWpGaD
Ibutilide—CACNB1—Neuronal System—HRAS—uterine cancer	0.00045	0.00159	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—CTNNB1—uterine cancer	0.000448	0.00159	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—SMAD3—uterine cancer	0.000446	0.00158	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—POLD1—uterine cancer	0.000443	0.00157	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—EP300—uterine cancer	0.000416	0.00147	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKR1C1—uterine cancer	0.000415	0.00147	CbGpPWpGaD
Ibutilide—CACNB1—Axon guidance—HRAS—uterine cancer	0.000399	0.00141	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—VEGFA—uterine cancer	0.000394	0.0014	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—NRAS—uterine cancer	0.000389	0.00138	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—POLD1—uterine cancer	0.000387	0.00137	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—ERBB2—uterine cancer	0.000375	0.00133	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—RRM2—uterine cancer	0.00037	0.00131	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—MET—uterine cancer	0.000366	0.0013	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKR1C1—uterine cancer	0.000362	0.00128	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—DCN—uterine cancer	0.000359	0.00127	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP11A1—uterine cancer	0.000338	0.0012	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—KRAS—uterine cancer	0.000335	0.00119	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—RRM2—uterine cancer	0.000322	0.00114	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKR1C3—uterine cancer	0.000319	0.00113	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—DCN—uterine cancer	0.000313	0.00111	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP11A1—uterine cancer	0.000295	0.00105	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—VEGFA—uterine cancer	0.000289	0.00102	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—NRAS—uterine cancer	0.000285	0.00101	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—HRAS—uterine cancer	0.000285	0.00101	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKR1C3—uterine cancer	0.000278	0.000987	CbGpPWpGaD
Ibutilide—KCNJ11—Neuronal System—HRAS—uterine cancer	0.00027	0.000955	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—ERBB2—uterine cancer	0.000267	0.000948	CbGpPWpGaD
Ibutilide—CACNB1—Developmental Biology—AKT1—uterine cancer	0.000251	0.000891	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—STK11—uterine cancer	0.000249	0.000881	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—CYP19A1—uterine cancer	0.000249	0.000881	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—KRAS—uterine cancer	0.000245	0.00087	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—CTNNB1—uterine cancer	0.000234	0.000829	CbGpPWpGaD
Ibutilide—KCNH2—Neuronal System—HRAS—uterine cancer	0.00023	0.000816	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—EP300—uterine cancer	0.000217	0.000771	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—STK11—uterine cancer	0.000217	0.000769	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—CYP19A1—uterine cancer	0.000217	0.000769	CbGpPWpGaD
Ibutilide—CACNA1C—Axon guidance—HRAS—uterine cancer	0.000209	0.000739	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—VEGFA—uterine cancer	0.000206	0.00073	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—NRAS—uterine cancer	0.000203	0.000721	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—MTHFR—uterine cancer	0.000187	0.000662	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—KRAS—uterine cancer	0.000175	0.000621	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—MTHFR—uterine cancer	0.000163	0.000578	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—HRAS—uterine cancer	0.000149	0.000527	CbGpPWpGaD
Ibutilide—CACNA1C—Developmental Biology—AKT1—uterine cancer	0.000131	0.000466	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PTEN—uterine cancer	0.000104	0.000369	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—EP300—uterine cancer	9.92e-05	0.000351	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PTEN—uterine cancer	9.07e-05	0.000321	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—EP300—uterine cancer	8.65e-05	0.000307	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—PIK3CA—uterine cancer	7.34e-05	0.00026	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—PIK3CA—uterine cancer	6.4e-05	0.000227	CbGpPWpGaD
Ibutilide—KCNJ11—Metabolism—AKT1—uterine cancer	5.99e-05	0.000212	CbGpPWpGaD
Ibutilide—CACNA1C—Metabolism—AKT1—uterine cancer	5.23e-05	0.000185	CbGpPWpGaD
